Advertisement

U.S. markets closed

S&P Futures
4,064.25
-11.25(-0.28%)
Dow Futures
33,993.00
-30.00(-0.09%)
Nasdaq Futures
12,046.25
-60.50(-0.50%)
Russell 2000 Futures
1,905.80
-4.70(-0.25%)
Crude Oil
81.21
+0.20(+0.25%)
Gold
1,932.00
+2.00(+0.10%)

Advertisement

Minerva Neurosciences, Inc. (NERV)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD

Visitors trend2W10W9M

2.2100

+0.0700

(+3.27%)

At close: 04:00PM EST

2.3000

+0.09

(+4.07%)

After hours:

06:21PM EST

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Bearishpattern detected

Momentum

View all chart patterns

Performance Outlook

Previous Close	2.1400
Open	2.1500
Bid	2.2000 x 1100
Ask	2.3000 x 800
Day's Range	2.1500 - 2.3400
52 Week Range	1.2600 - 15.2700
Volume	51,593
Avg. Volume	168,588

Market Cap	11.802M
Beta (5Y Monthly)	-0.07
PE Ratio (TTM)	N/A
EPS (TTM)	N/A
Earnings Date	N/A
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	N/A

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for NERV

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

Minerva Neurosciences, Inc
Analyst Report: Johnson & JohnsonJohnson & Johnson is a diversified healthcare company that develops, manufactures and markets products in three primary lines of business: Pharmaceuticals, Medical Devices and Diagnostics, and Consumer Products.
Rating
Fair Value
Economic Moat
8 hours agoArgus Research